| Landscape of somatic mutations in 560 breast cancer whole-genome sequences S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ... Nature 534 (7605), 47-54, 2016 | 2160 | 2016 |
| Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ... The lancet oncology 15 (4), 406-414, 2014 | 922 | 2014 |
| HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures H Davies, D Glodzik, S Morganella, LR Yates, J Staaf, X Zou, ... Nature medicine 23 (4), 517-525, 2017 | 916 | 2017 |
| Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases S Frentzas, E Simoneau, VL Bridgeman, PB Vermeulen, S Foo, ... Nature medicine 22 (11), 1294-1302, 2016 | 396 | 2016 |
| Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management E van Schooneveld, H Wildiers, I Vergote, PB Vermeulen, LY Dirix, ... Breast cancer research 17, 1-15, 2015 | 316 | 2015 |
| Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification I Van der Auwera, SJ Van Laere, GG Van den Eynden, I Benoy, ... Clinical cancer research 10 (23), 7965-7971, 2004 | 307 | 2004 |
| The topography of mutational processes in breast cancer genomes S Morganella, LB Alexandrov, D Glodzik, X Zou, H Davies, J Staaf, ... Nature communications 7 (1), 11383, 2016 | 270 | 2016 |
| The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper M Cristofanilli, JY Pierga, J Reuben, A Rademaker, AA Davis, DJ Peeters, ... Critical reviews in oncology/hematology 134, 39-45, 2019 | 242 | 2019 |
| Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study I Van der Auwera, GG Van den Eynden, CG Colpaert, SJ Van Laere, ... Clinical cancer research 11 (21), 7637-7642, 2005 | 233 | 2005 |
| Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer I Van der Auwera, D Peeters, IH Benoy, HJ Elst, SJ Van Laere, A Prove, ... British journal of cancer 102 (2), 276-284, 2010 | 228 | 2010 |
| Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and … E van Schooneveld, MCA Wouters, I Van der Auwera, DJ Peeters, ... Breast cancer research 14, 1-16, 2012 | 221 | 2012 |
| Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer JL Allensworth, MK Evans, F Bertucci, AJ Aldrich, RA Festa, P Finetti, ... Molecular oncology 9 (6), 1155-1168, 2015 | 206 | 2015 |
| International consensus guidelines for scoring the histopathological growth patterns of liver metastasis PJ Van Dam, EP Van Der Stok, LA Teuwen, GG Van den Eynden, ... British journal of cancer 117 (10), 1427-1441, 2017 | 191 | 2017 |
| Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study GG Van den Eynden, I Van der Auwera, SJ Van Laere, CG Colpaert, ... British journal of cancer 94 (11), 1643-1649, 2006 | 182 | 2006 |
| Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting DJE Peeters, B De Laere, GG Van den Eynden, SJ Van Laere, F Rothé, ... British journal of cancer 108 (6), 1358-1367, 2013 | 180 | 2013 |
| Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype I Van der Auwera, R Limame, P Van Dam, PB Vermeulen, LY Dirix, ... British journal of cancer 103 (4), 532-541, 2010 | 178 | 2010 |
| Pituitary progenitor cells tracked down by side population dissection J Chen, L Gremeaux, Q Fu, D Liekens, S Van Laere, H Vankelecom Stem cells 27 (5), 1182-1195, 2009 | 176 | 2009 |
| Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets SJ Van Laere, NT Ueno, P Finetti, P Vermeulen, A Lucci, FM Robertson, ... Clinical cancer research 19 (17), 4685-4696, 2013 | 157 | 2013 |
| The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer XB Trinh, WAA Tjalma, PB Vermeulen, G Van den Eynden, ... British journal of cancer 100 (6), 971-978, 2009 | 153 | 2009 |
| TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer B De Laere, S Oeyen, M Mayrhofer, T Whitington, PJ van Dam, ... Clinical cancer research 25 (6), 1766-1773, 2019 | 141 | 2019 |
